Home  -  About us  -  Editorial board  -  Search  -  Ahead of print  -  Current issue  -  Archives  -  Instructions  -  Subscribe  -  Contacts  -  Advertise - Login 
 
 
     
This article has been cited by
1Off-label uses of denosumab in metabolic bone diseases
Stergios A. Polyzos,Polyzois Makras,Symeon Tournis,Athanasios D. Anastasilakis
Bone.2019;129()115048
[DOI]
2Intralesional injection of triamcinolone hexacetonide as an alternative treatment for central giant cell lesions: a prospective study
R.L.M. Nogueira,R.L.V. Osterne,R.M.B. Lima Verde,N.O. Azevedo,R.C. Teixeira,R.B. Cavalcante
British Journal of Oral and Maxillofacial Surgery.2020;58(10)e283
[DOI]
3Treatment of central giant cell granuloma in children with denosumab
Michelle Choe,Valeria Smith,M. Fatih Okcu,Jade Wulff,Stephanie Gruner,Thierry A.G.M. Huisman,Rajkumar Venkatramani
Pediatric Blood & Cancer.2021;68(3)e283
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal
Facebook Icon